The initial study of Kroll and Amaya [2] using the transgenic Xenopus embryo protocol required a retrospective identification of transgenic individuals. Here, we use a technique that allows the identification of live transgenic embryos in early development through detection of GFP fusion proteins. This permits the analysis at early stages of the requirement for zygotic FGF signalling and transcriptional activation by the Caudal-related protein Xcad3 in the regulation of Hox genes. Figure 1a shows the constructs used in this study. The dominant-negative FGF receptor (XFD) [3] was cloned into the CS2+Myc vector [4] , which contains a strong eukaryotic promoter from cytomegalovirus (CMV) that drives ubiquitous expression from the transgene from the early gastrula stage [2] . In order to detect cells expressing the inhibitory FGF receptor in living embryos, GFP was fused in-frame to the carboxyl terminus of XFD-Myc (XFD-Myc-GFP). Xcad-EnR is an inhibitory mutant of Xcad3, overexpression of which blocks Hox gene activation by wild-type Xcad3 [5] . A GFP-tagged version of Xcad-EnR (Xcad-EnR-GFP) was produced by fusing GFP to the 3′ end of the homeobox of the original Xcad-EnR construct in CS2+. Figure 1b shows an RNase protection analysis of animal caps from embryos injected with eFGF mRNA alone or co-injected with XFD-Myc-GFP mRNA. Injection of eFGF mRNA induced strong expression of the mesodermal marker gene Xbra, while co-injection of eFGF and XFD-Myc-GFP mRNA completely repressed induction of Xbra [6] . The Myc and GFP tags within the XFD-Myc-GFP fusion protein did not interfere with its ability to block FGF signalling and repress the induction of Xbra by eFGF. Figure 1c shows that whereas injection of eFGF mRNA alone induced high levels of Hoxa-7 expression, co-injection of mRNA encoding Xcad-EnR or the fusion protein Xcad-EnR-GFP repressed the induction of Hoxa-7. In contrast, the levels of Xbra expression induced by eFGF remained near normal following overexpression of Xcad-EnR or Xcad-EnR-GFP, demonstrating that regulation of Xbra expression involves a distinct molecular pathway to the Xcad3 pathway.
XFD-Myc-GFP and Xcad-EnR-GFP fusion proteins retain biological activity

Inhibitory mutants of FGF-RI and Xcad3 tagged with GFP show appropriate subcellular localisation
Transgenic embryos were produced by restriction enzyme mediated integration (REMI) using both XFD-Myc-GFP and Xcad-EnR-GFP constructs and the subcellular localization of the fusion proteins was examined by confocal microscopy. Consistent with the previous study [2] , the fluorescence associated with CMV-driven expression from both transgenes could be detected by mid-gastrula stage 11. The GFP fusion tag allowed the rapid assessment of whether an embryo was expressing the transgene in all cells (see Supplementary material, published with this paper on the internet). For the purposes of this paper, only embryos that showed non-mosaic expression were analysed. Figure 2a Inhibition of FGF signalling by XFD or inhibition of Xcad3 activity by Xcad-EnR both resulted in characteristic disruption of posterior development, whereas anterior development was less affected. The expression of the XFD-Myc-GFP and Xcad-EnR-GFP transgenes also resulted in posterior truncations. Figure 2d shows a control three-day embryo that received a normal sperm, and Figure 2e shows the phenotype of a sibling embryo transgenic for XFD-Myc-GFP. As reported by Kroll and Amaya [2] , the phenotype of the XFD transgenic embryo was much the same as that resulting from injection of XFD mRNA [3, 7, 8] and the XFD fusion with GFP resulted in this same phenotype. Figure 2f shows the phenotype of a three-day Xcad-EnR-GFP transgenic embryo, which is similar to that resulting from Xcad-EnR mRNA injection [5] .
The use of the GFP tag allows efficient detection of transgene expression
In a given experiment, only 30-50% of individual embryos receiving a single transplanted sperm nucleus expressed the transgene. The inhibitory GFP fusion proteins have allowed us to identify homogeneous populations of nonmosaic transgenic embryos or non-transgenic sibling embryos from shortly after the activation of expression from the transgene. This has permitted the use of sensitive quantitative techniques for the analysis of effects on gene expression in pure populations of XFD-Myc-GFP and Xcad-EnR-GFP transgenic embryos. Figure 3 shows RNase protection analyses for embryos carrying the XFD-Myc-GFP transgene. Embryos were collected at late gastrula (stage 13) and tailbud (stage 25) stages and separated into transgenic and control populations on the basis of GFP fluorescence. The accuracy of selection was confirmed by the detection of strong GFP expression at all stages examined within the transgenic population and its complete absence within the control group (Figure 3a) . The efficacy of XFD-Myc-GFP at blocking FGF signalling in transgenic animals was confirmed by the block on Xbra expression at the stages examined (Figure 3b ).
FGF signalling is required for the initial activation but not later maintenance of posterior Hox gene expression
Overexpression of eFGF during gastrulation leads to an up-regulation of 'posterior' Hox genes [1] . Two such posterior Hox genes, Hoxa-7 (which is expressed in both ectoderm and mesoderm) and Hoxb-9 (which is expressed in neural tissue), are normally activated by the end of gastrulation. The activation of Hoxa-7 expression at the end of gastrula stages is blocked by overexpression of XFD [1] . The Hox genes are directly involved in the process of A-P specification and, given the activities and spatial expression of eFGF, we concluded that FGF signalling was involved in A-P specification. The initial transgenic study, however, showed that the expression of the spinal cord marker Hoxb-9 persists around the open blastopore of tailbud stage XFD transgenic embryos [2] . The authors concluded that FGF signalling was not involved in the regulation of A-P pattern. Experiments in the present study were designed to resolve the apparent contradiction in these two data sets [1, 2] . Figure 3 shows that CMV-driven expression of the XFD-Myc-GFP transgene greatly repressed the activation of Hoxa-7 and Hoxb-9 at the late gastrula stage 13. By tailbud stage 25, however, Hoxa-7 expression levels are similar to those in non-transgenic siblings (Figure 3a) . Figure 3b shows, consistent with Kroll and Amaya [2] , that by tailbud stage (stage 25), the expression of Hoxb-9 had also recovered to the level found in controls. As previously reported [1, 2] , the recovery of Hox gene expression was in tissue around the open blastopore (see Supplementary material). The re-establishment of Hox gene expression cannot be due to a reduction in expression from the transgene, as the level of GFP expression was maintained and the expression of Xbra continued to be repressed. Furthermore, the level of Xcad3 expression in XFD-Myc-GFP transgenic embryos was substantially lower than in control embryos at all stages, indicating that the recovery of posterior Hox gene expression in late neurula/early tailbud stages of embryos transgenic for XFD-Myc-GFP is unlikely to be regulated through Xcad3. These data indicate the existence of other FGF-independent regulators of posterior Hox gene expression that act during late neurula and early tailbud stages. The two-phase regulation of posterior Hox gene expression involving an early FGF-dependent activation phase and a later FGF-independent phase resolves the apparent conflict in data suggested by the two studies [1, 2] .
Later expression of posterior Hox genes is independent of Xcad3
Overexpression of Xcad-EnR resulted in a dramatic inhibition of posterior development and blocked the activation of the same Hox genes that are activated by Xcad3 [5] . Figure 4 shows RNase protection analysis of embryos transgenic for Xcad-EnR-GFP. Again, the accuracy of transgenic versus non-transgenic selection was confirmed Brief Communication 675 by the presence of high-level non-mosaic GFP expression in the transgenic group. As with XFD-Myc-GFP transgenic embryos, Hoxa-7 expression was also repressed during neurula stages in Xcad-EnR-GFP transgenic embryos ( Figure 4) . By tailbud stages, however, Hoxa-7 expression recovered to levels similar to control levels, indicating that although Xcad-EnR-GFP can repress Hoxa-7 expression during neurula stages, it is not able to do so during tailbud stages. This might indicate that binding of Xcad3 to its normal targets, such as regulatory regions in the Hox genes, may require cofactors that are present in gastrula and neurula stages but not during later neurula and tailbud stages. In any case, not only is this later phase of Hox gene regulation FGF independent, but it is also Xcad3 independent.
In conclusion, it is widely accepted that A-P patterning of the amphibian embryo occurs during gastrula stages as the dorsal mesoderm comes to underlie the neural plate. The advantages of using the tagged XFD-Myc-GFP and Xcad-EnR-GFP fusions in Xenopus embryos have allowed us to demonstrate that there is an initial phase in which the activation of posterior Hox gene expression is dependent on FGF signalling and Xcad3 activity. This is consistent with previous studies showing that FGF has the biological activity of a posteriorising or transforming factor [9] [10] [11] . During early tailbud stages, however, there is a second phase of Hox gene expression that is independent of FGF and Xcad3. These data indicate that the signals involved in the normal activation of posterior Hox genes during early neurula stages are different from those regulating the maintenance of their expression during tailbud stages.
Materials and methods
Construction of fusion proteins
The XFD used is the 64TXFD from Kroll and Amaya [2] and nucleotides 1-1215 were PCR cloned into the CS2+Myc plasmid [4] . XFD-Myc-GFP was made by blunt cloning BamHI-excised and filled GFP (the S64T variant from R. Tsien was used in this construct) into the Stu site of CS2-XFD-Myc. The CS2-Xcad3 plasmid used was as described in [1] . The Xcad3 repressor construct (CS2-Xcad-EnR) was made by cloning the sequence encoding amino acids 121-275 of Xcad3 into CS2-ENG-N (from D. Kessler). GFP2 was fused in-frame to the carboxyl end of Xcad-EnR at the BsrGI site, 3′ to the homeobox (GFP2 from E. Amaya, modified to be brighter by J. Haseloff and J. Pines).
Transgenic Xenopus
The technique used to generate transgenic embryos is as in [2] .
RNase protection analysis
RNA was prepared and analysed by RNase protection as described in [1] . Ornithine decarboxylase (ODC) was the loading control. The other probes used, Xbra [6] , Hoxb-9 [1] , Hoxa-7 and Xcad3, were as described in [1] . The GFP is a subclone of GFP2 (from E. Amaya) in Bluescript (Stratagene).
Supplementary material
Supplementary material published with this article on the internet includes a densiometric analysis of the gene expression studies from the work and photographic images of GFP fluorescence in transgenic specimens as well as in situ hybridisation of Hox gene expression.
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Figure S1
Uniform expression of the XFD-Myc-GFP transgene in a tailbud stage 25 embryo. Fluorescence image showing the ubiquitous expression of the GFP-tagged dominant-negative FGF receptor protein (XFD-Myc-GFP). Anterior is to the left.
Figure S2
The recovery of Hoxa-7 expression in a tailbud stage XFD-Myc-GFP transgenic embryo. The top embryo is at tailbud stage 27 and shows normal Hoxa-7 expression in the trunk and developing tail forming regions. The bottom stage 27 embryo is transgenic for XFD-Myc-GFP and shows the recovery of Hoxa-7 expression around the margins of the open blastopore (bp). Anterior is to the left.
